HighPoint Advisor Group’s Neurocrine Biosciences NBIX Stock Holding History

HighPoint Advisor Group’s Portfolio NBIX Stock Details NBIX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$403K	Hold
2025 Q3	$398K	Sell
2025 Q2	$361K	Buy
2025 Q1	$302K	Buy
2024 Q4	$286K	Buy
2024 Q3	$287K	Buy
2024 Q2	$272K	Sell
2024 Q1	$348K	Buy
2023 Q4	$352K	Buy
2022 Q2	$207K	Buy